Avidity Science(TM) Expands Water Purification Leadership Via Acquisition of Cascada(TM) and Operations Investment in Asia
PR83789
WATERFORD, Wisconsin, Apr. 28, 2020 /PRNewswire=KYODO JBN/--
Today Avidity Science announces significant steps in expanding its global
leadership in water purification solutions via the acquisition of the Cascada
Lab Water (
) Purification product line from Pall(R) China and establishing manufacturing
and distribution operations in Jiaxing, China. These investments expand
Avidity's portfolio of water purification solutions for science and provide
regional capabilities to enhance its support of both its life sciences and
biomedical research customers throughout Asia.
Photo - https://mma.prnewswire.com/media/1159468/Full_Line_v6.jpg
Logo - https://mma.prnewswire.com/media/716246/Avidity_Science_Logo.jpg
"We are excited about our investments as they add critical products,
capabilities, and services to our industry-leading water purification
portfolio," said Doug Lohse, chief executive officer, Avidity Science. "With
the addition of manufacturing and distribution capacity in China, we will now
be able to support the rapid growth of life-saving research throughout Asia."
The Cascada(TM) Lab Water Purification product line brings a full complement of
water purification solutions for all water types used in Life Sciences
research. "The portfolio offers a unique combination of flexible, secure
pretreatment design, dual water quality models covering all water types, and
informative operator interfaces which aligns with our customers' needs," said
Tim McDougle, managing director and head of Avidity's Global Lab Water business.
"We are pleased with this transaction and are confident that Avidity Science
will continue supporting our Cascada customers with strong product and service
offerings. We are excited for our Cascada associates to join the growing
Avidity Science team and ensuring a smooth business transition," said Allen Li,
vice president and general manager, Pall China.
Avidity's operations in Jiaxing provide manufacturing and distribution capacity
for its lab water range and biomedical solutions, including the Edstrom(TM)
portfolio. The new entity, Avidity Science Zhejiang Co. Ltd., also enables a
substantial increase in its commercial and service teams, which will provide
customers across Asia dedicated support options. "With the rapid growth of
biomedical research in Asia, it is critical that Avidity can deliver quality
products and timely support to safeguard the valuable research studies being
conducted in the region," said Laura Sarlin, vice president and head of
Avidity's Global Biomedical business.
Lohse concluded, "These investments represent another critical step in
achieving our Vision of enabling science to improve the quality of life. With
four acquisitions and a major capacity expansion in three years, Avidity
Science has established a diversified solution portfolio and global footprint
strengthening our position as a trusted partner to the research community."
About Avidity Science
Avidity Science is a worldwide leader in water purification systems and
laboratory equipment for scientific research and healthcare facilities. Since
1969, our mission has been to enable science to improve the quality of life.
With operations in the United States, Europe and Asia, we are a trusted partner
to the global research community through unrivaled technology and support.
For more information about these investments and our company, please visit
www.AvidityScience.com.
Source - Avidity Science
CONTACT: Amber Hegemann, +1-262-534-5181 Ext 254,
Amber.Hegemann@AvidityScience.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。